| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Genetic | 31 | 2023 | 944 | 4.840 |
Why?
|
| Polymorphism, Single Nucleotide | 37 | 2024 | 2399 | 3.330 |
Why?
|
| Genome-Wide Association Study | 23 | 2024 | 1670 | 2.980 |
Why?
|
| Genetics, Population | 17 | 2019 | 405 | 2.660 |
Why?
|
| Bayes Theorem | 22 | 2023 | 369 | 2.650 |
Why?
|
| Single-Cell Analysis | 5 | 2024 | 146 | 2.520 |
Why?
|
| Software | 13 | 2024 | 665 | 2.370 |
Why?
|
| Sequence Analysis, RNA | 11 | 2024 | 232 | 2.340 |
Why?
|
| Algorithms | 19 | 2024 | 1875 | 2.150 |
Why?
|
| Models, Statistical | 10 | 2020 | 575 | 1.820 |
Why?
|
| Genomics | 7 | 2020 | 761 | 1.590 |
Why?
|
| Genetic Variation | 20 | 2021 | 1371 | 1.510 |
Why?
|
| Gene Expression Regulation | 19 | 2021 | 1975 | 1.490 |
Why?
|
| Haplotypes | 13 | 2019 | 637 | 1.400 |
Why?
|
| Gene Expression Profiling | 15 | 2023 | 1429 | 1.320 |
Why?
|
| Genome | 7 | 2020 | 386 | 1.290 |
Why?
|
| Genotype | 20 | 2023 | 1848 | 1.260 |
Why?
|
| Data Interpretation, Statistical | 4 | 2019 | 299 | 1.230 |
Why?
|
| Quantitative Trait Loci | 19 | 2024 | 607 | 1.220 |
Why?
|
| Linkage Disequilibrium | 7 | 2022 | 477 | 1.190 |
Why?
|
| Elephants | 4 | 2015 | 17 | 1.180 |
Why?
|
| Recombination, Genetic | 11 | 2018 | 444 | 1.110 |
Why?
|
| Phenotype | 16 | 2024 | 2439 | 1.040 |
Why?
|
| Genome, Human | 13 | 2018 | 767 | 0.920 |
Why?
|
| Genetic Techniques | 4 | 2008 | 73 | 0.910 |
Why?
|
| Gene Expression | 9 | 2023 | 1310 | 0.830 |
Why?
|
| Principal Component Analysis | 5 | 2024 | 160 | 0.720 |
Why?
|
| DNA | 5 | 2018 | 1307 | 0.690 |
Why?
|
| Humans | 81 | 2024 | 89157 | 0.670 |
Why?
|
| Computational Biology | 4 | 2020 | 542 | 0.670 |
Why?
|
| Workflow | 1 | 2019 | 80 | 0.660 |
Why?
|
| Information Dissemination | 1 | 2019 | 114 | 0.640 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2015 | 377 | 0.630 |
Why?
|
| Computer Simulation | 11 | 2023 | 1097 | 0.630 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 988 | 0.610 |
Why?
|
| Sequence Alignment | 1 | 2018 | 353 | 0.610 |
Why?
|
| Transcriptome | 7 | 2024 | 628 | 0.610 |
Why?
|
| Population | 2 | 2008 | 35 | 0.590 |
Why?
|
| DNA Damage | 1 | 2019 | 371 | 0.570 |
Why?
|
| Chromosome Mapping | 8 | 2020 | 1076 | 0.560 |
Why?
|
| Linear Models | 2 | 2014 | 422 | 0.520 |
Why?
|
| Response Elements | 1 | 2015 | 65 | 0.510 |
Why?
|
| Population Dynamics | 2 | 2019 | 134 | 0.500 |
Why?
|
| Microsatellite Repeats | 4 | 2015 | 147 | 0.500 |
Why?
|
| Lipoproteins, LDL | 1 | 2015 | 85 | 0.500 |
Why?
|
| Alleles | 7 | 2018 | 1135 | 0.500 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 338 | 0.480 |
Why?
|
| Multifactorial Inheritance | 3 | 2024 | 169 | 0.470 |
Why?
|
| Cluster Analysis | 3 | 2023 | 371 | 0.460 |
Why?
|
| Interleukin-2 | 1 | 2013 | 251 | 0.430 |
Why?
|
| RNA | 1 | 2017 | 578 | 0.420 |
Why?
|
| Mutation | 6 | 2019 | 4137 | 0.410 |
Why?
|
| Arabidopsis | 1 | 2015 | 320 | 0.410 |
Why?
|
| Carcinoma | 1 | 2015 | 443 | 0.410 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 294 | 0.390 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 2753 | 0.390 |
Why?
|
| Emigration and Immigration | 3 | 2008 | 48 | 0.380 |
Why?
|
| Likelihood Functions | 4 | 2022 | 251 | 0.360 |
Why?
|
| Evolution, Molecular | 6 | 2018 | 839 | 0.350 |
Why?
|
| Crossing Over, Genetic | 2 | 2006 | 33 | 0.350 |
Why?
|
| Transcription Factors | 5 | 2015 | 1652 | 0.350 |
Why?
|
| Diploidy | 2 | 2007 | 31 | 0.340 |
Why?
|
| Databases, Genetic | 6 | 2012 | 263 | 0.330 |
Why?
|
| Mathematical Computing | 1 | 2008 | 21 | 0.330 |
Why?
|
| Gene-Environment Interaction | 3 | 2018 | 111 | 0.330 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2020 | 116 | 0.320 |
Why?
|
| Gene Frequency | 3 | 2015 | 685 | 0.320 |
Why?
|
| Genetic Markers | 2 | 2007 | 478 | 0.310 |
Why?
|
| Primates | 4 | 2018 | 155 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 559 | 0.310 |
Why?
|
| Genetics, Medical | 1 | 2008 | 52 | 0.310 |
Why?
|
| Selection, Genetic | 6 | 2018 | 509 | 0.300 |
Why?
|
| Commerce | 1 | 2007 | 31 | 0.280 |
Why?
|
| Gene Conversion | 1 | 2006 | 24 | 0.280 |
Why?
|
| Monte Carlo Method | 3 | 2015 | 186 | 0.280 |
Why?
|
| Crohn Disease | 1 | 2013 | 758 | 0.280 |
Why?
|
| Animals | 21 | 2024 | 27330 | 0.280 |
Why?
|
| RNA, Messenger | 6 | 2020 | 2011 | 0.270 |
Why?
|
| Artifacts | 1 | 2008 | 245 | 0.270 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 1157 | 0.270 |
Why?
|
| Simvastatin | 4 | 2014 | 105 | 0.260 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 481 | 0.260 |
Why?
|
| Dentin | 1 | 2004 | 7 | 0.250 |
Why?
|
| Neoplasms | 3 | 2019 | 3037 | 0.250 |
Why?
|
| Polymorphism, Genetic | 5 | 2012 | 824 | 0.240 |
Why?
|
| Regression Analysis | 2 | 2018 | 590 | 0.240 |
Why?
|
| Amidinotransferases | 2 | 2014 | 5 | 0.240 |
Why?
|
| Africa | 4 | 2010 | 101 | 0.240 |
Why?
|
| Cell Line | 10 | 2021 | 2495 | 0.230 |
Why?
|
| Geography | 5 | 2008 | 227 | 0.230 |
Why?
|
| Muscular Diseases | 2 | 2014 | 64 | 0.230 |
Why?
|
| Models, Biological | 4 | 2019 | 1764 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 2338 | 0.220 |
Why?
|
| Deoxyribonuclease I | 2 | 2012 | 28 | 0.200 |
Why?
|
| Biological Evolution | 3 | 2019 | 965 | 0.200 |
Why?
|
| Markov Chains | 4 | 2013 | 127 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 5 | 2019 | 866 | 0.200 |
Why?
|
| Genetic Linkage | 1 | 2003 | 624 | 0.200 |
Why?
|
| Models, Theoretical | 2 | 2015 | 491 | 0.200 |
Why?
|
| Glucocorticoids | 3 | 2013 | 358 | 0.190 |
Why?
|
| Poisson Distribution | 1 | 2021 | 50 | 0.190 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 25 | 0.180 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2020 | 44 | 0.180 |
Why?
|
| Sepsis | 1 | 2024 | 319 | 0.170 |
Why?
|
| Cytokines | 1 | 2024 | 802 | 0.170 |
Why?
|
| Terminology as Topic | 1 | 2021 | 221 | 0.170 |
Why?
|
| Tropical Climate | 1 | 2019 | 31 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 956 | 0.170 |
Why?
|
| Oncogenes | 1 | 2019 | 92 | 0.170 |
Why?
|
| Animal Distribution | 1 | 2019 | 21 | 0.170 |
Why?
|
| DNA, Ancient | 1 | 2019 | 18 | 0.170 |
Why?
|
| Polyploidy | 1 | 2018 | 18 | 0.160 |
Why?
|
| DNA Transposable Elements | 2 | 2018 | 174 | 0.160 |
Why?
|
| Coffea | 1 | 2018 | 2 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 1 | 2018 | 69 | 0.160 |
Why?
|
| Europe | 4 | 2019 | 321 | 0.160 |
Why?
|
| Cytosine | 1 | 2019 | 128 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2020 | 324 | 0.150 |
Why?
|
| Cell Cycle | 1 | 2020 | 509 | 0.150 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 69 | 0.150 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 313 | 0.150 |
Why?
|
| Genome, Plant | 1 | 2018 | 95 | 0.150 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 373 | 0.150 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 507 | 0.150 |
Why?
|
| Adenosine | 1 | 2020 | 237 | 0.150 |
Why?
|
| Gene Silencing | 1 | 2018 | 178 | 0.150 |
Why?
|
| Birds | 1 | 2019 | 165 | 0.150 |
Why?
|
| Blastocyst | 1 | 2017 | 35 | 0.150 |
Why?
|
| Calibration | 2 | 2008 | 104 | 0.140 |
Why?
|
| Pan troglodytes | 3 | 2009 | 199 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2024 | 261 | 0.140 |
Why?
|
| Environment | 1 | 2018 | 224 | 0.140 |
Why?
|
| Base Sequence | 2 | 2018 | 2327 | 0.130 |
Why?
|
| Open Reading Frames | 1 | 2016 | 119 | 0.130 |
Why?
|
| Transients and Migrants | 1 | 2015 | 7 | 0.130 |
Why?
|
| Oxygen | 1 | 2021 | 742 | 0.130 |
Why?
|
| Molecular Biology | 1 | 2016 | 89 | 0.130 |
Why?
|
| Ribosomes | 1 | 2016 | 115 | 0.130 |
Why?
|
| Animal Migration | 1 | 2015 | 29 | 0.130 |
Why?
|
| India | 2 | 2019 | 123 | 0.130 |
Why?
|
| Hypoxia | 1 | 2021 | 650 | 0.130 |
Why?
|
| Exons | 3 | 2012 | 451 | 0.130 |
Why?
|
| Genes, Lethal | 1 | 2015 | 53 | 0.120 |
Why?
|
| Gene Flow | 1 | 2015 | 91 | 0.120 |
Why?
|
| Genes, Recessive | 1 | 2015 | 87 | 0.120 |
Why?
|
| Hybridization, Genetic | 1 | 2015 | 106 | 0.120 |
Why?
|
| Epigenomics | 1 | 2015 | 103 | 0.120 |
Why?
|
| Papio | 1 | 2015 | 82 | 0.120 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 2062 | 0.120 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2013 | 131 | 0.120 |
Why?
|
| RNA Stability | 2 | 2012 | 89 | 0.120 |
Why?
|
| Protein Binding | 2 | 2015 | 1487 | 0.120 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 529 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 388 | 0.120 |
Why?
|
| Asthma | 1 | 2022 | 977 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2013 | 6 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2013 | 24 | 0.110 |
Why?
|
| Male | 13 | 2020 | 42309 | 0.110 |
Why?
|
| Organ Specificity | 3 | 2020 | 272 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2004 | 142 | 0.110 |
Why?
|
| Interferon-gamma | 2 | 2024 | 451 | 0.110 |
Why?
|
| Helicobacter pylori | 2 | 2003 | 37 | 0.110 |
Why?
|
| Chromosomes, Human, X | 2 | 2020 | 55 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 661 | 0.100 |
Why?
|
| Population Groups | 1 | 2012 | 41 | 0.100 |
Why?
|
| DNA Modification Methylases | 1 | 2012 | 28 | 0.100 |
Why?
|
| DNA Footprinting | 1 | 2012 | 18 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 199 | 0.100 |
Why?
|
| Species Specificity | 4 | 2018 | 684 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 170 | 0.100 |
Why?
|
| Female | 12 | 2021 | 46078 | 0.100 |
Why?
|
| Conservation of Natural Resources | 2 | 2015 | 82 | 0.100 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 53 | 0.100 |
Why?
|
| Cadherins | 1 | 2012 | 163 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2013 | 3376 | 0.100 |
Why?
|
| Population Density | 2 | 2019 | 61 | 0.100 |
Why?
|
| Dextroamphetamine | 1 | 2012 | 108 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 153 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 345 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 113 | 0.090 |
Why?
|
| Homozygote | 2 | 2007 | 204 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2013 | 466 | 0.090 |
Why?
|
| Disease | 2 | 2020 | 90 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2008 | 695 | 0.080 |
Why?
|
| Nigeria | 3 | 2019 | 156 | 0.080 |
Why?
|
| Mice | 3 | 2024 | 11743 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2553 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2011 | 344 | 0.080 |
Why?
|
| Sequence Deletion | 2 | 2006 | 205 | 0.080 |
Why?
|
| Transcription Initiation Site | 3 | 2017 | 46 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1855 | 0.080 |
Why?
|
| Lipids | 1 | 2010 | 271 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2009 | 210 | 0.080 |
Why?
|
| Lymphocytes | 3 | 2016 | 471 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 79 | 0.080 |
Why?
|
| Quality Control | 1 | 2008 | 117 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2008 | 80 | 0.080 |
Why?
|
| Forests | 2 | 2019 | 22 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2012 | 657 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 192 | 0.070 |
Why?
|
| Macaca mulatta | 1 | 2009 | 466 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2010 | 429 | 0.070 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2006 | 2 | 0.070 |
Why?
|
| Crime | 1 | 2007 | 37 | 0.070 |
Why?
|
| Brain | 1 | 2017 | 2281 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 738 | 0.070 |
Why?
|
| Genetics, Behavioral | 1 | 2006 | 22 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1241 | 0.060 |
Why?
|
| Automation | 1 | 2006 | 111 | 0.060 |
Why?
|
| Interferon Type I | 1 | 2006 | 178 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 79 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2007 | 684 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 353 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1176 | 0.060 |
Why?
|
| Biometry | 1 | 2005 | 66 | 0.060 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2020 | 124 | 0.060 |
Why?
|
| Kinetics | 1 | 2007 | 1528 | 0.060 |
Why?
|
| Genetic Heterogeneity | 1 | 2003 | 63 | 0.060 |
Why?
|
| Genetic Drift | 1 | 2003 | 37 | 0.060 |
Why?
|
| Chromosomes | 1 | 2003 | 97 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2003 | 37 | 0.050 |
Why?
|
| Sex Factors | 2 | 2020 | 1063 | 0.050 |
Why?
|
| Coenzyme A | 1 | 2022 | 15 | 0.050 |
Why?
|
| Aged | 3 | 2015 | 19119 | 0.050 |
Why?
|
| Amino Acids | 1 | 2022 | 245 | 0.050 |
Why?
|
| Internet | 1 | 2003 | 318 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 2014 | 0.050 |
Why?
|
| Pedigree | 2 | 2015 | 969 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 207 | 0.050 |
Why?
|
| Terminator Regions, Genetic | 2 | 2012 | 14 | 0.050 |
Why?
|
| Cells | 1 | 2020 | 32 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2024 | 699 | 0.040 |
Why?
|
| Genes | 1 | 2021 | 305 | 0.040 |
Why?
|
| Causality | 1 | 2020 | 80 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2020 | 222 | 0.040 |
Why?
|
| Middle Aged | 3 | 2015 | 25910 | 0.040 |
Why?
|
| Research Design | 1 | 2003 | 597 | 0.040 |
Why?
|
| Cholesterol | 2 | 2013 | 358 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 2019 | 16 | 0.040 |
Why?
|
| Introns | 2 | 2012 | 299 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2020 | 275 | 0.040 |
Why?
|
| Pravastatin | 2 | 2010 | 17 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2019 | 48 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 117 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2021 | 231 | 0.040 |
Why?
|
| Chromatin | 2 | 2012 | 397 | 0.040 |
Why?
|
| Ipomoea batatas | 1 | 2018 | 1 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2020 | 152 | 0.040 |
Why?
|
| China | 1 | 2019 | 233 | 0.040 |
Why?
|
| Plant Breeding | 1 | 2018 | 8 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 613 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2019 | 192 | 0.040 |
Why?
|
| Temperature | 1 | 2019 | 400 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 211 | 0.040 |
Why?
|
| Biodiversity | 1 | 2019 | 205 | 0.040 |
Why?
|
| Noise | 1 | 2017 | 26 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 5483 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2020 | 537 | 0.030 |
Why?
|
| Central African Republic | 1 | 2015 | 2 | 0.030 |
Why?
|
| Democratic Republic of the Congo | 1 | 2015 | 5 | 0.030 |
Why?
|
| Africa, Western | 1 | 2015 | 11 | 0.030 |
Why?
|
| Grassland | 1 | 2015 | 6 | 0.030 |
Why?
|
| Y Chromosome | 1 | 2015 | 29 | 0.030 |
Why?
|
| Uganda | 1 | 2015 | 36 | 0.030 |
Why?
|
| Liver | 2 | 2011 | 1205 | 0.030 |
Why?
|
| Fertility | 1 | 2015 | 116 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2015 | 187 | 0.030 |
Why?
|
| Adult | 4 | 2022 | 26542 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 2412 | 0.030 |
Why?
|
| Phylogeny | 2 | 2011 | 1183 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Pregnanolone | 1 | 2012 | 8 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2880 | 0.030 |
Why?
|
| Human Genome Project | 1 | 2012 | 19 | 0.030 |
Why?
|
| Drosophila | 1 | 2017 | 521 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 247 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2012 | 20 | 0.030 |
Why?
|
| Statistical Distributions | 1 | 2012 | 9 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2012 | 8 | 0.030 |
Why?
|
| Placebos | 1 | 2012 | 214 | 0.030 |
Why?
|
| HapMap Project | 1 | 2012 | 47 | 0.030 |
Why?
|
| Endangered Species | 1 | 2011 | 24 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2012 | 60 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 9 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 329 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 42 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 376 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 108 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 155 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 125 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7154 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 253 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2010 | 65 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 92 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 2011 | 165 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2010 | 57 | 0.020 |
Why?
|
| Heptanoic Acids | 1 | 2010 | 71 | 0.020 |
Why?
|
| Monocytes | 1 | 2010 | 218 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 392 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 293 | 0.020 |
Why?
|
| Pyrroles | 1 | 2010 | 187 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2008 | 97 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1715 | 0.020 |
Why?
|
| Sample Size | 1 | 2008 | 128 | 0.020 |
Why?
|
| Edar Receptor | 1 | 2007 | 2 | 0.020 |
Why?
|
| Antiporters | 1 | 2007 | 18 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2012 | 551 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2006 | 59 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 111 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2006 | 135 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2006 | 211 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 306 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 740 | 0.020 |
Why?
|
| Heterozygote | 1 | 2006 | 373 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 292 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 971 | 0.010 |
Why?
|
| Pattern Recognition, Automated | 1 | 2005 | 217 | 0.010 |
Why?
|
| Polynesia | 1 | 2003 | 3 | 0.010 |
Why?
|
| Social Problems | 1 | 2003 | 10 | 0.010 |
Why?
|
| Americas | 1 | 2003 | 19 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1296 | 0.010 |
Why?
|
| Asia | 1 | 2003 | 98 | 0.010 |
Why?
|
| Indians, North American | 1 | 2003 | 47 | 0.010 |
Why?
|
| Agriculture | 1 | 2003 | 39 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 2003 | 198 | 0.010 |
Why?
|
| Language | 1 | 2003 | 154 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 685 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 9243 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 3027 | 0.010 |
Why?
|
| United States | 1 | 2011 | 6965 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 887 | 0.010 |
Why?
|